Literature DB >> 15990017

Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.

Anesa Ahamad1, Warren D'Souza, Mohammad Salehpour, Revathy Iyer, Susan L Tucker, Anuja Jhingran, Patricia J Eifel.   

Abstract

PURPOSE: To determine the influence of target-volume expansion on the reduction in small-bowel dose achieved with use of intensity-modulated radiation therapy (IMRT) vs. standard conformal treatment of the pelvis after hysterectomy, and to investigate the influence of patient body habitus on the normal-tissue sparing achieved with use of IMRT. METHODS AND MATERIALS: A clinical target volume (CTV) was contoured on each of 10 planning computed tomography scans of patients who had been treated for cervical or endometrial cancer after a hysterectomy. Treatment planning was based on vaginal CTVs and regional nodal CTVs. To account for internal motion, margins were added to form an initial planning target volume (PTVA) as follows: 0.0 mm were added to the regional nodal CTV; 10 mm were added anteriorly to the vaginal CTV; and 5 mm were added to the vaginal CTV in all other directions. Two further PTVs (PTVB and PTVC) were produced by a 5-mm expansion of PTVA to give PTVB and a further 5-mm expansion to give PTVC. Treatment plans for all 3 PTVs were produced by use of 2 conformal fields (2FC), 4 conformal fields (4FC), or IMRT to deliver 45 Gy to more than 97% of the PTV. The primary goal of IMRT was to spare small bowel. The change in sparing that accompanied the increase in margin size was assessed by comparison of dose-volume histograms that resulted from PTVA, PTVB, and PTVC. Measured patient dimensions were correlated with bowel sparing.
RESULTS: Significantly less small bowel was irradiated by IMRT than by 2FC (p < 0.0001) or 4FC (p < 0.0001) for doses greater than 25 Gy. Significantly less rectum was irradiated by IMRT than by 2FC (p < 0.0001) or 4FC (p < 0.0001). Significantly less bladder was irradiated by IMRT than by 2FC (p < 0.0001). However, the magnitude of the sparing achieved by use of IMRT decreased as margins increased. In particular, the volume of small bowel spared by IMRT vs. 2FC or 4FC decreased as margin size increased (p = 0.0002 and p = 0.008 for 2FC and 4FC, respectively). The amount of normal-tissue sparing achieved by use of IMRT vs. 4FC was inversely correlated with patient body mass index.
CONCLUSION: Because the small-bowel sparing achieved with use of IMRT is markedly reduced by relatively small expansions of the target volume, accurate target delineation, highly reproducible patient immobilization, and a clear understanding of internal-organ motion are needed to achieve optimal advantage in the use of IMRT over conventional methods of posthysterectomy pelvic radiation therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15990017     DOI: 10.1016/j.ijrobp.2004.12.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

1.  Vaginal displacement during course of adjuvant radiation for cervical cancer: results from a prospective IG-IMRT study.

Authors:  S Chopra; A Patidar; T Dora; N Moirangthem; S N Paul; R Engineer; U Mahantshetty; S K Shrivastava
Journal:  Br J Radiol       Date:  2014-08-19       Impact factor: 3.039

2.  Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

Authors:  Ann H Klopp; Anamaria R Yeung; Snehal Deshmukh; Karen M Gil; Lari Wenzel; Shannon N Westin; Kent Gifford; David K Gaffney; William Small; Spencer Thompson; Desiree E Doncals; Guilherme H C Cantuaria; Brian P Yaremko; Amy Chang; Vijayananda Kundapur; Dasarahally S Mohan; Michael L Haas; Yong Bae Kim; Catherine L Ferguson; Stephanie L Pugh; Lisa A Kachnic; Deborah W Bruner
Journal:  J Clin Oncol       Date:  2018-07-10       Impact factor: 44.544

3.  Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.

Authors:  Xue-lian Du; Xiu-gui Sheng; Tao Jiang; Hao Yu; Yu-feng Yan; Rong Gao; Chun-hua Lu; Qing-shui Li
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

4.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

5.  Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer.

Authors:  Jason D Wright; Israel Deutsch; Elizabeth T Wilde; Cande V Ananth; Alfred I Neugut; Sharyn N Lewin; Zainab Siddiq; Thomas J Herzog; Dawn L Hershman
Journal:  Gynecol Oncol       Date:  2013-03-13       Impact factor: 5.482

6.  Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report.

Authors:  Abel Cordoba; Philippe Nickers; Emmanuelle Tresch; Bernard Castelain; Eric Leblanc; Fabrice Narducci; Florence Le Tinier; Anne Lesoin; Thomas Lacornerie; Eric Lartigau
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-03

7.  A comparative dosimetric study of cervical cancer patients with para-aortic lymph node metastasis treated with volumetric modulated arc therapy vs. 9-field intensity-modulated radiation therapy.

Authors:  Yaqin Wu; Biqing Zhu; Jingjing Han; Hanzi Xu; Zhen Gong; Yongqin Yang; Jian Huang; Emei Lu
Journal:  Ann Transl Med       Date:  2019-11

8.  Impact of different optimization strategies on the compatibility between planned and delivered doses during radiation therapy of cervical cancer.

Authors:  Agata Jodda; Tomasz Piotrowski; Marta Kruszyna-Mochalska; Julian Malicki
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-12

9.  Optimizing image guidance frequency and implications on margins for gynecologic malignancies.

Authors:  Carmen Stromberger; Arne Gruen; Waldemar Wlodarczyk; Volker Budach; Christhardt Koehler; Simone Marnitz
Journal:  Radiat Oncol       Date:  2013-05-02       Impact factor: 3.481

10.  Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy.

Authors:  Takahiro Oike; Tatsuya Ohno; Shin-ei Noda; Hiro Sato; Tomoaki Tamaki; Hiroki Kiyohara; Ken Ando; Takashi Nakano
Journal:  J Radiat Res       Date:  2012-12-14       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.